We are live on ! Find out more
LS

Leelyn Smith Portfolio holdings

AUM $822M
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
AUM
$336M
AUM Growth
+$23.3M
Cap. Flow
+$15.2M
Cap. Flow %
4.53%
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 10.61%
2 Healthcare 7.68%
3 Consumer Discretionary 7.22%
4 Financials 5.18%
5 Consumer Staples 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLP icon
376
Alerian MLP ETF
AMLP
$13.2B
-636
Closed -$16K
ANY icon
377
Sphere 3D
ANY
$20.6M
$0 ﹤0.01%
1
AON icon
378
Aon
AON
$75.7B
-380
Closed -$80K
AVNW icon
379
Aviat Networks
AVNW
$272M
$0 ﹤0.01%
4
BIPC icon
380
Brookfield Infrastructure
BIPC
$4.88B
-2
Closed
CL icon
381
Colgate-Palmolive
CL
$73.2B
-1,095
Closed -$94K
ESS icon
382
Essex Property Trust
ESS
$18.7B
-140
Closed -$33K
IGSB icon
383
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
-798
Closed -$44K
INO icon
384
Inovio Pharmaceuticals
INO
$133M
$0 ﹤0.01%
1
NVT icon
385
nVent Electric
NVT
$25B
$0 ﹤0.01%
6
PINS icon
386
Pinterest
PINS
$13.3B
-500
Closed -$33K
PNR icon
387
Pentair
PNR
$10B
$0 ﹤0.01%
6
TSN icon
388
Tyson Foods
TSN
$20.2B
$0 ﹤0.01%
5
VIAV icon
389
Viavi Solutions
VIAV
$9.24B
$0 ﹤0.01%
+2
New +$32
WAB icon
390
Wabtec
WAB
$50.1B
$0 ﹤0.01%
2
WFC icon
391
Wells Fargo
WFC
$254B
$0 ﹤0.01%
7
XONE
392
DELISTED
The ExOne Company
XONE
$0 ﹤0.01%
5
BMY.RT
393
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-1,295
Closed -$1K

Similar funds

Leelyn Smith's Q1 2021 Portfolio in Review

As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.

  • Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
  • Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
  • Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
  • Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
  • Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
  • Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
  • Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.

Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.